Is Allscripts Healthcare Solutions Inc. (MDRX) Price Targeted To Increase?


As of Friday close, Allscripts Healthcare Solutions Inc.’s (NASDAQ:MDRX) stock was down -$0.29, moving down -2.16 percent to $13.12. The average number of shares traded per day over the past five days has been 1,632,800 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.76 fall in that time frame. In the last twenty days, the average volume was 1,417,860, while in the previous 50 days, it was 1,224,338.

Since last month, MDRX stock retreated -25.75%. Shares of the company fell to $13.07 on 03/16/23, the lowest level in the past month. A 52-week high of $23.25 was reached on 01/13/23 after having rallying from a 52-week low of $13.07. Since the beginning of this year, MDRX’s stock price has dropped by -25.62% or -$4.52, and marked a new high 5 times. However, the stock has declined by -43.57% since its 52-week high.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free.


MDRX stock investors should be aware that Allscripts Healthcare Solutions Inc. (MDRX) stock had its last reported insider trading activity 30 days ago on Feb 16. Poulton Richard J., the CEO of the company, disposed of 10,000 shares for $17.33 on Feb 16. It resulted in a $173,304 divestment by the insider. Poulton Richard J. sold 10,000 shares at an average price of $17.38 on Feb 15. The insider now owns 679,017 shares following the transaction. On Dec 12, SVP General Counsel Vakharia Tejal sold 8,642 shares at $18.42 apiece. The transaction was valued at $159,193.

Valuation Metrics

Right now, Allscripts Healthcare Solutions Inc. (MDRX) has a P/E ratio of about 13.94. The stock’s beta is 0.99. Besides these, the trailing price-to-sales (P/S) ratio of 1.75, the price-to-book (PB) ratio of 1.23, and the price-to-cash flow ratio of 9.26 may also be considered.

Financial Health

In the three months ended September 29, Allscripts Healthcare Solutions Inc.’s quick ratio stood at 3.20, while its current ratio was 3.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.17, and the total debt-to-equity ratio was 0.17. On the profitability front, the trailing twelve-month gross margin is 48.40% percent. In the year ended September 29, operating margins totaled 8.10%. Based on annual data, MDRX earned $619.57 million in gross profit and brought in $1.5 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 3.30%. Return on equity (ROE) for the past 12 months was 4.70%.

In Allscripts Healthcare Solutions Inc.’s quarter-end financial report for September 29, it reported total debt of $200.33 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. MDRX’s revenue fell -143.07% to $150.9 million during the quarter, while net income inched up to $151.92 million. While analysts expected Allscripts Healthcare Solutions Inc. to report $0.19 quarterly earnings, the actual figure was $0.23 per share, beating the consensus estimate by 21.10%. During the quarter, the company generated $38.81 million in EBITDA. The liabilities of Allscripts Healthcare Solutions Inc. were 513.64 million at the end of its most recent quarter ended September 29, and its total debt was $218.81 million. The value of shareholders’ equity is $109.26 million.

Technical Picture

This quick technical analysis looks at Allscripts Healthcare Solutions Inc.’s (MDRX) price momentum. With a historical volatility rate of 16.31%, the RSI 9-day stood at 18.37% on 17 March.

With respect to its five-day moving average, the current Allscripts Healthcare Solutions Inc. price is down by -5.48% percent or -$0.76. At present, MDRX shares trade -24.90% below its 20-day simple moving average and -7.93% percent below its 100-day simple moving average. However, the stock is currently trading approximately -25.07% below its SMA50 and -23.23% below its SMA200.

Stochastic coefficient K was 5.90% and Stochastic coefficient D was 6.10%, while ATR was 0.56. Given the Stochastic reading of 1.31% for the 14-day period, the RSI (14) reading has been calculated as 22.50%. As of today, the MACD Oscillator reading stands at -0.47, while the 14-day reading stands at -0.93.

Analyst Ratings

Allscripts Healthcare Solutions Inc. downgraded its rating on Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) to a Neutral in a note to investors on February 01, 2023. The analysts firm previously had an Overweight rating on the stock.Allscripts Healthcare Solutions Inc. (MDRX) has been rated Overweight by analysts. According to 1 brokerage firm, MDRX is a sell, and 4 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Allscripts Healthcare Solutions Inc. stock as buy, with 6 recommending it as overweight.

With a median target price of $20.50, the current consensus forecast for the stock is $17.00 – $26.00. Based on these forecasts, analysts predict Allscripts Healthcare Solutions Inc. (MDRX) will achieve an average price target of $20.19.


Please enter your comment!
Please enter your name here